IV Valproate in generalized convulsive status epilepticus: A systematic review

European Journal of Neurology

Volumn 19, Issue 9, 2012, Pages 1180-1191

  Brigo, F ^a   Storti, M ^a   Del Felice, A ^a   Fiaschi, A ^a   Bongiovanni, L G ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Clinical trials randomized controlled; Clinical trials systematic review meta analysis; Status epilepticus; Valproic acid

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; ETIRACETAM; MIDAZOLAM; PHENYTOIN; PLACEBO; VALPROIC ACID;

COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; DATA EXTRACTION; DRUG EFFICACY; DRUG SAFETY; EMBASE; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATUS EPILEPTICUS; VALPROIC ACID; YOUNG ADULT;

EID: 84865284798     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03606.x     Document Type: Review

References (37)

1. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12: 316-325.
2. Cascino GD. Generalized convulsive status epilepticus. Mayo Clin Proc 1996; 71: 787-792.
3. Berg AT, Shinnar S, Levy SR, Testa FM. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol 1999; 45: 618-623.
4. Berg AT, Shinnar S, Testa FM, et al. Status epilepticus after the initial diagnosis of epilepsy in children. Neurology 2004; 63: 1027-1034.
5. Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia 1996; 37: S74-S80.
6. Giroud M, Gras D, Escousse A, Dumas R, Venaud G. Use of injectable valproic acid in status epilepticus: a pilot study. Drug Invest 1993; 5: 154-159.
7. Alehan FK, Morton LD, Pellock JM. Treatment of absence status with intravenous valproate. Neurology 1999; 52: 889-890.
8. Chez MG, Hammer MS, Loeffel M, Nowinski C, Bagan BT. Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid. J Child Neurol 1999; 14: 239-242.
9. Hovinga CA, Chicella MF, Rose DF, Eades SK, Dalton JT, Phelps SJ. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother 1999; 33: 579-584.
10. Kaplan PW. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999; 30: 1-4.
11. White JR, Cantos CS. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus. J Child Neurol 1999; 4: 822-823.
12. Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus. Neurology 2000; 54: 1201-1202.
13. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000; 55: 722-724.
14. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000; 54: 2188-2189.
15. Yu KT, Mills S, Thompson N, Cunanan C. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia 2003; 44: 724-726.
16. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005; 64: 353-355.
17. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999; 40: 120-122.
18. Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last? Ann Neurol 2001; 49: 659-664.
19. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002; 31: 150-153.
20. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. (accessed 15/April/2011)
21. Jha S, Jose M, Patel R. Intravenous sodium valproate in status epilepticus. Neurol India 2003; 51: 421-422.
22. Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004; 63: 1507-1508.
23. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-experience in 102 adult patients. Seizure 2005; 14: 164-169.
24. Chen L, Feng P, Wang J, Liu L, Zhou D. Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus. J Clin Neurosci 2009; 16: 524-526.
25. Sillanpää M, Pihlaja T. Oxcarbazepine (GP 47 680) in the treatment of intractable seizures. Acta Paediatr Hung 1988-1989; 29: 359-364.
26. Bittencourt PR, Richens A. Efficient serum concentrations after single doses of antiepileptic drugs: concept of loading-dose. Arq Neuropsiquiatr 1985; 43: 11-16.
27. Thanh TN, Chiron C, Dellatolas G, et al. Long-term efficacy and tolerance of stiripentol in severe myoclonic epilepsy of infancy (Dravet's syndrome). Arch Pediatr 2002; 9: 1120-1127.
28. Scholtes FB, Hendriks MP, Renier WO. Cognitive deterioration and electrical status epilepticus during slow sleep. Epilepsy Behav 2005; 6: 167-173.
29. Mahmoudian T, Najafian M. Comparing the effect of intravenous midazolam with rectal sodium valproate in controlling of children with refractory status epilepticus. J Res Med Sci 2006; 11: 1-5.
30. Tripathi M, Vibha D, Choudhary N, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure 2010; 19: 109-111.
31. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006; 67: 340-342.
32. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007; 16: 527-532.
33. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 2007; 22: 1191-1197.
34. Gilad R, Izkovitz N, Dabby R, et al. Treatment of status epilepticus and acuterepetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand 2008; 118: 296-300.
35. Chen WB, Gao R, Su YY, et al. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Eur J Neurol 2011; 9: 1391-1396.
36. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005; 19: CD003723; doi:10.1002/14651858.CD003723.pub2
37. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792-798.